Related references
Note: Only part of the references are listed.Oxidized GAPDH transfers S-glutathionylation to a nuclear protein Sirtuin-1 leading to apoptosis
Syed Husain Mustafa Rizvi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Role of Reductive versus Oxidative Stress in Tumor Progression and Anticancer Drug Resistance
Kyung-Soo Chun et al.
CELLS (2021)
Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53
Patrizia Malkomes et al.
ONCOGENE (2021)
ent-Kaurane diterpenoids induce apoptosis and ferroptosis through targeting redox resetting to overcome cisplatin resistance
Yong Sun et al.
REDOX BIOLOGY (2021)
Cyst(e)ine in nutrition formulation promotes colon cancer growth and chemoresistance by activating mTORC1 and scavenging ROS
Jiao Wu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)
GSTpi regulates VE-cadherin stabilization through promoting S-glutathionylation of Src
Yang Yang et al.
REDOX BIOLOGY (2020)
Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis
Fang Zhang et al.
FUTURE ONCOLOGY (2020)
Cancer-associated Fibroblasts induce epithelial-mesenchymal transition via the Transglutaminase 2-dependent IL-6/IL6R/STAT3 axis in Hepatocellular Carcinoma
Changchang Jia et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)
Characterisation of naturally occurring isothiocyanates as glutathione reductase inhibitors
Xia Li et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Large tumor suppressor kinase 2 overexpression attenuates 5-FU-resistance in colorectal cancer via activating the JNK-MIEF1-mitochondrial division pathway
Weilong Yao et al.
CANCER CELL INTERNATIONAL (2019)
Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche
Salvatore Condello et al.
CANCER RESEARCH (2018)
DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells
Kyoung Ah Kang et al.
REDOX BIOLOGY (2018)
Glutathione reductase-mediated thiol oxidative stress suppresses metastasis of murine melanoma cells
Xia Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Persistent Oxidative Stress in Vestibular Schwannomas After Stereotactic Radiation Therapy
Zachary N. Robinett et al.
OTOLOGY & NEUROTOLOGY (2018)
Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui et al.
DRUG RESISTANCE UPDATES (2018)
SMYD2 glutathionylation contributes to degradation of sarcomeric proteins
Dhanushka N. P. Munkanatta Godage et al.
NATURE COMMUNICATIONS (2018)
Activated hepatic stellate cells promote epithelial-to-mesenchymal transition in hepatocellular carcinoma through transglutaminase 2-induced pseudohypoxia
Hui Ma et al.
COMMUNICATIONS BIOLOGY (2018)
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
Allimuthu T. Dharmaraja
JOURNAL OF MEDICINAL CHEMISTRY (2017)
2-Acetylamino-3-[4-(2-acetylamino-2-carboxyethylsulfanylcarbonylamino) phenyl carbamoylsulfanyl] propionic acid, a glutathione reductase inhibitor, induces G2/M cell cycle arrest through generation of thiol oxidative stress in human esophageal cancer cells
Xia Li et al.
ONCOTARGET (2017)
Transglutaminase Interaction with α6/β4-Integrin Stimulates YAP1-Dependent ΔNp63α Stabilization and Leads to Enhanced Cancer Stem Cell Survival and Tumor Formation
Matthew L. Fisher et al.
CANCER RESEARCH (2016)
The role of glutathione reductase and related enzymes on cellular redox homoeostasis network
Narciso Couto et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer
Bowen Du et al.
MOLECULES (2016)
Reactive Oxygen Species in Cancer: A Dance with the Devil
Paul T. Schumacker
CANCER CELL (2015)
Transglutaminase-2 is Involved in Cell Apoptosis of Osteosarcoma Cell Line U2OS Under Hypoxia Condition
Wei Wang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2015)
HOI-02 induces apoptosis and G2-M arrest in esophageal cancer mediated by ROS
C. Zhang et al.
CELL DEATH & DISEASE (2015)
Bcl-2 stabilization by paxillin confers 5-fluorouracil resistance in colorectal cancer
D-W Wu et al.
CELL DEATH AND DIFFERENTIATION (2015)
TRANSGLUTAMINASE REGULATION OF CELL FUNCTION
Richard L. Eckert et al.
PHYSIOLOGICAL REVIEWS (2014)
Evaluation of a dithiocarbamate derivative as an inhibitor of human glutaredoxin-1
Satya S. Sadhu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Transglutaminase 2 Contributes to Apoptosis Induction in Jurkat T Cells by Modulating Ca2+ Homeostasis via Cross-Linking RAP1GDS1
Yu-Fan Hsieh et al.
PLOS ONE (2013)
Microtubule S-glutathionylation as a potential approach for antimitotic agents
Wei Chen et al.
BMC CANCER (2012)
Oxidative Stress Induced S-glutathionylation and Proteolytic Degradation of Mitochondrial Thymidine Kinase 2
Ren Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
TGM2 Is a Novel Marker for Prognosis and Therapeutic Target in Colorectal Cancer
Norikatsu Miyoshi et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer
Kapil Mehta et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Transglutaminase 2 as a cisplatin resistance marker in non-small cell lung cancer
Kang-Seo Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells
G-Y Jang et al.
ONCOGENE (2010)
Increase in thiol oxidative stress via glutathione reductase inhibition as a novel approach to enhance cancer sensitivity to X-ray irradiation
Yong Zhao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Characterization of a Novel Dithiocarbamate Glutathione Reductase Inhibitor and Its Use as a Tool to Modulate Intracellular Glutathione
Teresa Seefeldt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype
Binod Kumar et al.
CANCER RESEARCH (2008)
Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling
Liyun Cao et al.
CARCINOGENESIS (2008)
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer
Arnit Verma et al.
CLINICAL CANCER RESEARCH (2008)
Thiol chemistry and specificity in redox signaling
Christine C. Winterbourn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis
Kaori Ishikawa et al.
SCIENCE (2008)
Tissue transglutaminase-mediated chemoresistance in cancer cells
Amit Verma et al.
DRUG RESISTANCE UPDATES (2007)
Tissue transglutaminase expression promotes cell attachment, invasion and survival in breast cancer cells
L. S. Mangala et al.
ONCOGENE (2007)
Transglutaminase-mediated activation of nuclear transcription Factor-kappa B in cancer cells: A new therapeutic opportunity
Amit Verma et al.
CURRENT CANCER DRUG TARGETS (2007)
Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis
Amit Verma et al.
CANCER RESEARCH (2006)
Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells
J. F. Herman et al.
ONCOGENE (2006)
Tissue array-based expression of transglutaminase-2 in human breast and ovarian cancer
Christian F. Singer et al.
CLINICAL & EXPERIMENTAL METASTASIS (2006)
Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase
M Deponte et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The glutathione reductase inhibitor cartmustine induces an influx of Ca2+ in PC12 cells
N Doroshenko et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Activation of the Ras-ERK pathway inhibits retinoic acid-induced stimulation of tissue transglutaminase expression in NIH3T3 cells
MA Antonyak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb.
JE Boehm et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
